| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.42 | 0.06 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |